Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 212-639-8410
Are you Dr. Bastian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 13 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Boris Bastian, MD is a pathologist in New York, New York. He is currently licensed to practice medicine in New York and California. He is affiliated with University of California San Francisco Medical Center at Mount Zion and is a Professor of Dermatology at UCSF.
Education & Training
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 2001 - 2025
NY State Medical License 2010 - 2015
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2012
- America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2011
Publications & Presentations
PubMed
- Primary Melanoma of the Urinary Bladder: Clinical, Histopathologic, and Comprehensive Molecular Analysis of a Rare Tumor.Neslihan Kayraklioglu, Emily Chan, Boris Bastian, Steven R Long
International Journal of Surgical Pathology. 2025-04-01 - Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stroma.Simon F Roy, Nnenna G Agim, Adnan Mir, Kasey L Couts, Travis Vandergriff
The British Journal of Dermatology. 2025-02-27 - 2 citationsGenetic evolution of keratinocytes to cutaneous squamous cell carcinoma.Bishal Tandukar, Delahny Deivendran, Limin Chen, Noel Cruz-Pacheco, Harsh Sharma
Biorxiv. 2024-12-02
Press Mentions
Evolution of Melanoma Reveals Opportunities for InterventionJuly 9th, 2018
Correcting a Blind SpotJune 30th, 2018
American Skin Association Announces Abby S. And Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma Skin Cancer ResearchApril 17th, 2018- Join now to see all
Grant Support
- Pre-cancer atlas of skin cancerUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Molecular and immunologic evolution of melanomas from pre-neoplastic lesionsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2017–2025
- The KIT Signaling Pathway As A Therapeutic Target In MelanomaNational Cancer Institute2011–2012
- The GNAQ Pathway As A Therapeutic Target In Uveal MelanomaNational Cancer Institute2010–2012
- The GNAQ Pathway As A Therapeutic Target In Uveal MelanomaNational Cancer Institute2011
- Biomarker Discovery For The Classification Of MelanomaNational Cancer Institute2010–2011
- Biomarker Discovery For The Classification Of MelanomaNational Cancer Institute2008–2011
- Genetic Expression Of Lentigo Malignant Melanoma - UCSF ConsortiumNational Cancer Institute2007–2009
- Genomic Analysis Of Squamous Cell CarcinomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2007
- Genetic Expression Of Lentigo Malignant Melanoma, Proj. 2 - UCSF ConsortiumNational Cancer Institute2005–2006
- Classification Of Ambiguous Melanocytic TumorsNational Cancer Institute2002–2005
